Beth Okutan

Title: Innovations by Beth Okutan

Introduction

Beth Okutan is a notable inventor based in London, Canada. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of multi-phase soft gelatin dosage forms. With a total of three patents to her name, her work focuses on enhancing the delivery of active pharmaceutical ingredients.

Latest Patents

Beth Okutan's latest patents include innovative formulations that combine statins and omega-3 fatty acids for encapsulation. One of her patents describes a multi-phase soft gelatin dosage form that comprises at least one preformed solid dosage form containing a statin compound and at least one liquid fill phase with omega-3 fatty acids. This invention is particularly useful for combining solid and liquid dosage forms for single ingestion. Additionally, she has developed a method and apparatus for manufacturing these multi-phase soft gelatin dosage forms, which may also include nutraceuticals, nutritional supplements, and therapeutic substances.

Career Highlights

Beth Okutan is currently employed at Catalent Ontario Limited, where she continues to innovate in the pharmaceutical industry. Her work has been instrumental in advancing the formulation of soft gelatin capsules, making them more effective for patients.

Collaborations

Some of her coworkers include Peter Robert Draper and James Edward Draper, who contribute to her innovative projects and research efforts.

Conclusion

Beth Okutan's contributions to pharmaceutical formulations demonstrate her commitment to improving healthcare through innovation. Her patents reflect a deep understanding of the complexities involved in drug delivery systems.